(Update) Acalabrutinib in CLL and MCL
Obinutuzumab
Update Venetoclax in CLL
Acalabrutinib
Zanubrutinib
Cancer.gov
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic
UpToDate
NCCN Guidelines for Patients for CLL